Dongjun Lin

机构：Sun Yat-sen University, The Seventh Affiliated Hospital of Sun Yat-sen University · ORCID：0000-0002-3201-5544

发表论文 110 篇 · 总被引 1364 次 · h-index 21

代表论文

• Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study (2024 · Clinical Cancer Research · 被引 12)
• Black phosphorus nanosheets-based platform for B-cell lymphoma chemo-photothermal therapy (2025 · Chinese Chemical Letters · 被引 4)
• A prophylactic tyrosine kinase inhibitor strategy based on measurable residual disease pre‐transplantation for Ph + acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A prospective multicenter cohort study (2024 · American Journal of Hematology · 被引 4)
• Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukaemia: A multicentre cohort study (2025 · British Journal of Haematology · 被引 3)
• Dual redox-responsive CO2-generating nanoparticles assembled from one-step synthesized l-cystine-based biodegradable polymers for enhanced chemotherapy of tumors (2025 · Chinese Chemical Letters · 被引 2)
• Dynamic forecasting module for chronic graft-versus-host disease progression based on a disease-associated subpopulation of B cells: a multicenter prospective study (2025 · EBioMedicine · 被引 2)